{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "PlasmaTech Biopharmaceuticals' Announces Initiation of Enrollment of MuGard Trial for Afinitor (Everolimus; Novartis) - Related Stomatitis at UCLA Breast Cancer Center",
    "author_name": "Plasmatech Biopharmaceuticals",
    "author_url": "http:\/\/www.plasmatechbio.com\/"
}